Skip to main content
. 2022 Jul 21;11:20480040221114651. doi: 10.1177/20480040221114651

Table 5.

Dyslipidemia based on HIV status of the participants at the zewditu memorial hospital in Addis Ababa, Ethiopia, 2021.

HIV-positive HIV-negative COR (95% CI) P value AOR (95% CI) P value
BMI
Over-weight and obesity (≥ 25 kg/m2) 92 (31.9) 63 (28.4) 1.185 (.808, 1.737) .386
Normal (<25 kg/m2) 196 (68.1) 159 (71.6)
Obesity (NCEP)
WC >35 inch in Women and >40 inch in men 68 (23.6) 79 (35.6) .559 (.380,.824) .003 .316 (.186,.538) <.001
WC </ = 35 inch in Women and </ = 40 inch in men 220 (76.4) 143 (64.4)
High FBS or DM
FBS ≥126 or confirmed DM 50 (17.4) 90 (40.5) .308 (.205,.462) <.001 .330 (.203,.535) <.001
Else (<126) 238 (82.6) 132 (59.5)
High BP or confirmed HTN
SBP>120 mmHg and DBP> 80mmHg 129 (44.9) 156 (70.3) .345 (.345,.500) <.001 .339 (.227,.507) <.001
Else 158 (55.1) 66 (29.7)
MUH_NM
BMI <125 Kg/m2 but with DM/HTN 168 (58.3) 156 (70.3) .592 (.409,.858) .006 .583 (.317, 1.074) .084
Else 120 (41.7) 66 (29.7)
MHO
BMI ≥125 Kg/m2 but without DM/HTN 80 (27.8) 37 (16.7) 1.923 (1.242, 2.977) .003 1.206 (.563, 2.582) .630
Else 208 (72.2) 185 (83.3)
High TC
≥240 mg/dl 41 (14.2) 36 (16.2) .536 (.527, 1.395) .858
< 240 mg/dl 247 (85.8) 186 (83.8)
High Non-HDL-C
≥130 mg/dl 163 (56.6) 131 (59.0) .906 (.635, 1.292) .585
<130 mg/dl 125 (43.4) 91 (41.0)
High LDL-C
≥160 mg/dl 42 (14.6) 31 (14.0) 1.052 (.637, 1.736) .843
<160 mg/dl 246 (85.4) 191 (86.0)
LDL/HDL ratio
>/ = 2.5 moderate to high 137 (47.6) 101 (45.5) 1.087 (.765, 1.544) .642
<2.5 normal 151 (52.4) 121 (54.5)
TC/HDL ratio
>/ = 3. 5 (M) & >/ = 3.0 (F) Moderate to high 202 (70.1) 156 (70.3) .994 (.678, 1.457) .974
<3.5 (M) & <3.0 (F) Normal 86 (29.9) 66 (29.7)
TG/HDL ratio
>/ = 3. 5 (M) & >/ = 3.0 (F) Moderate to high 123 (42.7) 92 (41.4) 1.053 (.739, 1.502) .774
<3.5 (M) & <3.0 (F) Normal 165 (57.3) 130 (58.6)
WHtR
>.50 193 (67.0) 199 (58.1) 1.465 (1.019, 2.105) .039 2.973 (1.831, 4.828) <.001
Else 95 (33.0) 93 (41.9)